Fluorine-18-labeled boronophenylalanine positron emission tomography for oral cancers: Qualitative and quantitative analyses of malignant tumors and normal structures in oral and maxillofacial regions

Oncology Letters

Volumn 2, Issue 3, 2011, Pages 423-427

  Ariyoshi, Yasunori ^a   Shimahara, Masashi ^a   Kimura, Yoshihiro ^a   Ito, Yuichi ^a   Shimahara, Takeshi ^a   Miyatake, Shin Ichi ^b   Kawabata, Shinji ^b  

^a Department of Dentistry and Oral Surgery   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Boron neutron capture therapy; Fluorine 18 labeled boronophenylalanine positron emission tomography; Oral cancer

Indexed keywords

4 BORONOPHENYLALANINE F 18; ANTINEOPLASTIC AGENT; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTHERMIC THERAPY; ISOTOPE LABELING; LYMPH NODE METASTASIS; MALE; MAXILLA; MELANOMA; MOUTH CANCER; NEUTRON CAPTURE THERAPY; POSITRON EMISSION TOMOGRAPHY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA;

EID: 79953275925     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.265     Document Type: Article

References (20)

1. 18F-FDG-PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter-and intraobserver agreement. J Oral Maxillofac Surg 68: 21-27, 2010.
2. 18F-FDG-PET. Ann Nucl Med 22: 533-538, 2008.
3. Ariyoshi Y, Miyatake S, Kimura Y, Shimahara T, Kawabata S, Nagata K, Suzuki M, Maruhashi A, Ono K and Shimahara M: Boron neutron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis. Oncol Rep 18: 861-866, 2007.
4. Kimura Y, Ariyoshi Y, Miyatake S, Shimahara M, Kawabata S and Ono K: Boron neutron capture therapy for papillary cystadenocarcinoma in the upper lip: A case report. Int J Oral Maxillofac Surg 38: 293-295, 2009.
5. Miyatake S, Kawabata S, Kajimoto Y, Aoki A, Yokoyama K, Yamada M, Kuroiwa T, Tsuji M, Imahori Y, Kirihata M, Sakurai Y, Masunaga S, Nagata K, Maruhashi A and Ono K: Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages. J Neurosurg 103: 1000-1009, 2005.
6. 10B-compound. Lancet 2: 388-389, 1989.
7. Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, Kirihata M, Nakazawa M and Yura Y: Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isotopes 61: 1069-1073, 2004.
8. Barth RF, Coderre JA, Vicente MG and Blue TE: Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 11: 3987-4002, 2005.
9. Ono K, Masunaga S, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T and Akuta K: Radiological evidence suggesting heterogenous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 34: 1081-1086, 1996.
10. Ono K, Masunaga S, Kinashi Y, Nagata K, Suzuki M, Sakurai Y, Maruhashi A, Kato I, Nakazawa M, Ariyoshi Y and Kimura Y: Neutron irradiation under continuous BPA injection for solving the problem of heterogenous distribution of BPA. In: Advances in Neutron Capture Therapy. Takamatsu, Plenum Press, New York, pp27-30, 2006.
11. Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T and Fujii R: Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part II. Clin Cancer Res 4: 1833-1841, 1998.
12. Nichols TL, Kabalka GW, Miller LF, Khan MK and Smith GT: Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. Med Phys 29: 2351-2358, 2002.
13. Kabalka GW, Nichols TL, Smith GT, Miller LF, Khan MK and Busse PM: The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. J Neurooncol 62: 187-195, 2003.
14. Havu-Auren K, Kiiski J, Lehtio K, Eskola O, Kulvik M, Vuorinen V, Oikonen V, Vahatalo J, Jaaskelainen J and Minn H: Uptake of 4-borono-2-(18F)fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET. Eur J Nucl Med Mol Imaging 34: 87-94, 2007.
15. Deantonio L, Beldi D, Gambaro G, Loi G, Brambilla M, Inglese E and Krengli M: FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Radiat Oncol 3: 29, 2008.
16. 18F-FDP PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR Images. J Nucl Med 49: 1422-1428, 2008.
17. Busse PM, Harling OK, Palmer MR, Kiger WS III, Kaplan J, Kaplan I, Chuang CF, Goorley JT, Riley KJ, Newton TH, Santa Cruz GA, Lu XQ and Zamenhof RG: A critical examination of the results from the Harvard-MIT NCT program phase 1 clinical trial of neutron capture therapy for intracranial disease. J Neurooncol 62: 111-121, 2003.
18. Coderre JA, Morris GM, Kalef-Ezra J, Micca PL, Ma R, Youngs K and Cordon CR: The effects of boron neutron capture irradiation on oral mucosa: evaluation using a rat tongue model. Radiat Res 152: 113-118, 1999.
19. 18F-BPA-PET. Head Neck 28: 850-855, 2006.
20. Miyashita M, Miyatake S, Imahori Y, Yokoyama K, Kawabata S, Kajimoto Y, Shibata MA, Otsuki Y, Kirihata M, Ono K and Kuroiwa T: Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas. J Neurooncol 89: 239-246, 2008.